The strain of bird flu has killed twenty-seven and sickened one hundred and twenty people, in China.
Greffex was sent the genetic makeup of the virus, in March.
They believe that their vaccine will be capable of blocking and perhaps curing H7N9.
Tests will continue for the next two to three months, then clinical trials can begin.
If all goes well mass production could begin by October.
No comments:
Post a Comment